Tapewire

Nasdaq · USD

DCGO

DocGo Inc.

Export transactions ↓
Tapewire entity
7359
SEC CIK
0001822359
Parsed reports
170

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 15, 2022 Filed Dec 20, 2022 01:01 UTC
Sugrue StephenChief Compliance Officer
GrantOptions to purchase Common Stock · Derivative 250 $0.00 Strike: $6.93 $0.00
Disclosure

SEC source: 0001213900-22-081110 · ownership.xml · derivative · entry 1

Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250

Underlying: Common Stock · 250 shares

Expires 2032-12-15

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock.

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 15, 2023 through December 15, 2025, in each case, subject to the terms of the Plan.

Read SEC document
December 15, 2022 Filed Dec 20, 2022 01:01 UTC
Smedra IraDirector
GrantCommon Stock 46,176 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-081109 · ownership.xml · nonDerivative · entry 1

Smedra Ira · CIK 0001892208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,176

F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

Read SEC document
December 15, 2022 Filed Dec 20, 2022 06:09 UTC GrantRestricted Stock Units · Derivative 23,088 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-081131 · ownership.xml · derivative · entry 1

TRAVERS JAMES M · CIK 0001258177 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,088

Underlying: Common Stock · 23,088 shares

Expires not disclosed

F1 · derivative.exercise_price: The restricted stock units ("RSUs") were granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") and will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

F1 · derivative.exercise_date: The restricted stock units ("RSUs") were granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") and will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

F1 · derivative.expiration_date: The restricted stock units ("RSUs") were granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") and will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

Read SEC document
November 17, 2022 Filed Nov 21, 2022 23:54 UTC GrantStock Option (right to buy) · Derivative 81,425 $0.00 Strike: $7.13 $0.00
Disclosure

SEC source: 0001213900-22-074320 · ownership.xml · derivative · entry 1

Leite Etalvina · CIK 0001825203 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,425

Underlying: Common Stock · 81,425 shares

Expires 2032-11-17

F1 · shares: Represents stock options granted under the DocGo Inc. 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock.

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments on each of the first, second, and third anniversaries of the grant date, subject to the terms of the Plan.

Read SEC document
November 04, 2022 Filed Dec 23, 2022 09:15 UTC Disposition to issuerCommon Stock 7,131 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-082394 · ownership.xml · nonDerivative · entry 2

TRAVERS JAMES M · CIK 0001258177 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Travers Holdings LLC

Disclosed balance after: 516,028

F3 · shares: Pursuant to Section 3.2(c)(i) of the Stock Escrow Agreement, dated August 15, 2021, by and among Issuer, Motion Acquisition LLC, and Continental Stock Transfer & Trust Company (as assigned from time to time), on November 4, 2022, Travers Holdings LLC forfeited 7,131 shares of Common Stock for no consideration.

F2 · ownership.nature: Securities are held by Travers Holdings LLC. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Read SEC document
November 04, 2022 Filed Dec 23, 2022 14:12 UTC Disposition to issuerCommon Stock 6,986 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-082392 · ownership.xml · nonDerivative · entry 2

Burdiek Michael J · CIK 0001324293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 505,561

F2 · shares: Pursuant to Section 3.2(c)(i) of the Stock Escrow Agreement, dated August 15, 2021, by and among Issuer, Motion Acquisition LLC, and Continental Stock Transfer & Trust Company (as assigned from time to time), on November 4, 2022, Mr. Burdiek forfeited 6,986 shares of Common Stock for no consideration.

Read SEC document
September 16, 2022 Filed Dec 23, 2022 09:15 UTC Exercise / conversionWarrants to purchase Common Stock · Derivative 443,432 Not disclosed Strike: $11.50 Not disclosed
Disclosure

SEC source: 0001213900-22-082394 · ownership.xml · derivative · entry 3

TRAVERS JAMES M · CIK 0001258177 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Travers Holdings LLC

Disclosed balance after: 0

Underlying: Common Stock · 99,019 shares

Expires 2026-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior Issuer's redemption of warrants, Travers Holdings LLC exercised its 443,432 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement.

F1 · price: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior Issuer's redemption of warrants, Travers Holdings LLC exercised its 443,432 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement.

F2 · ownership.nature: Securities are held by Travers Holdings LLC. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Read SEC document
September 16, 2022 Filed Dec 23, 2022 09:15 UTC GrantCommon Stock 99,019 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-082394 · ownership.xml · nonDerivative · entry 1

TRAVERS JAMES M · CIK 0001258177 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Travers Holdings LLC

Disclosed balance after: 523,159

F1 · shares: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior Issuer's redemption of warrants, Travers Holdings LLC exercised its 443,432 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement.

F1 · price: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior Issuer's redemption of warrants, Travers Holdings LLC exercised its 443,432 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement.

F2 · ownership.nature: Securities are held by Travers Holdings LLC. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Read SEC document
September 16, 2022 Filed Dec 23, 2022 14:12 UTC Exercise / conversionWarrants to purchase Common Stock · Derivative 434,437 Not disclosed Strike: $11.50 Not disclosed
Disclosure

SEC source: 0001213900-22-082392 · ownership.xml · derivative · entry 3

Burdiek Michael J · CIK 0001324293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 97,010 shares

Expires 2026-12-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior to the redemption of warrants, Mr. Burdiek exercised his 434,437 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement.

F1 · price: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior to the redemption of warrants, Mr. Burdiek exercised his 434,437 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement.

Read SEC document
September 16, 2022 Filed Dec 23, 2022 14:12 UTC GrantCommon Stock 97,010 Not disclosed Not disclosed
Disclosure

SEC source: 0001213900-22-082392 · ownership.xml · nonDerivative · entry 1

Burdiek Michael J · CIK 0001324293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 512,547

F1 · shares: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior to the redemption of warrants, Mr. Burdiek exercised his 434,437 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement.

F1 · price: On August 15, 2022, pursuant to the Warrant Agreement, dated October 14, 2020 ("Warrant Agreement"), by and between Issuer and Continental Stock Transfer & Trust Company ("Continental"), Issuer issued a notice of mandatory redemption of all issued and outstanding warrants to acquire Common Stock. On September 16, 2022, immediately prior to the redemption of warrants, Mr. Burdiek exercised his 434,437 private warrants to acquire common stock on a cashless basis at a conversion ratio of 0.2233 shares of Common Stock per private warrant, as established pursuant to the terms of the Warrant Agreement.

Read SEC document
July 27, 2022 Filed Jul 28, 2022 07:05 UTC OtherWarrants to purchase Common Stock · Derivative 443,432 $0.00 Strike: $11.50 $0.00
Disclosure

SEC source: 0001213900-22-042181 · ownership.xml · derivative · entry 2

TRAVERS JAMES M · CIK 0001258177 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Travers Holdings LLC

Disclosed balance after: 443,432

Underlying: Common Stock · 443,432 shares

Expires 2026-12-05

F1 · kind: On July 27, 2022, Motion Sponsor LLC ("Sponsor") made a pro rata distribution of shares of Issuer common stock and private placement warrants to acquire shares of Issuer common stock to its member and interest holders. As part of this distribution, Travers Holdings LLC ("Travers Holdings"), a member and interest holder of Sponsor, received 424,140 shares of Issuer and 443,432 private placement warrants to acquire 443,432 shares of Issuer.

F2 · ownership.nature: Securities are held by Travers Holdings. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Read SEC document
July 27, 2022 Filed Jul 28, 2022 07:05 UTC OtherCommon Stock 424,140 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-042181 · ownership.xml · nonDerivative · entry 1

TRAVERS JAMES M · CIK 0001258177 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Travers Holdings LLC

Disclosed balance after: 424,140

F1 · kind: On July 27, 2022, Motion Sponsor LLC ("Sponsor") made a pro rata distribution of shares of Issuer common stock and private placement warrants to acquire shares of Issuer common stock to its member and interest holders. As part of this distribution, Travers Holdings LLC ("Travers Holdings"), a member and interest holder of Sponsor, received 424,140 shares of Issuer and 443,432 private placement warrants to acquire 443,432 shares of Issuer.

F2 · ownership.nature: Securities are held by Travers Holdings. Mr. Travers and Susan D. Travers are the managers of Travers Holdings and have shared voting and dispositive power over the securities of Issuer held by Travers Holdings. Mr. Travers and Susan D. Travers each disclaim beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Read SEC document
July 27, 2022 Filed Jul 28, 2022 11:05 UTC OtherWarrants to purchase Common Stock · Derivative 434,437 $0.00 Strike: $11.50 $0.00
Disclosure

SEC source: 0001213900-22-042182 · ownership.xml · derivative · entry 2

Burdiek Michael J · CIK 0001324293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 434,437

Underlying: Common Stock · 434,437 shares

Expires 2026-12-05

F1 · kind: On July 27, 2022, Motion Sponsor LLC ("Sponsor") made a pro rata distribution of shares of Issuer common stock and private placement warrants to acquire shares of Issuer common stock to its member and interest holders. As part of this distribution, Mr. Burdiek, a member and interest holder of Sponsor, received 415,537 shares of Issuer and 434,437 private placement warrants to acquire 434,437 shares of Issuer.

Read SEC document
July 27, 2022 Filed Jul 28, 2022 11:05 UTC OtherCommon Stock 415,537 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-042182 · ownership.xml · nonDerivative · entry 1

Burdiek Michael J · CIK 0001324293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 415,537

F1 · kind: On July 27, 2022, Motion Sponsor LLC ("Sponsor") made a pro rata distribution of shares of Issuer common stock and private placement warrants to acquire shares of Issuer common stock to its member and interest holders. As part of this distribution, Mr. Burdiek, a member and interest holder of Sponsor, received 415,537 shares of Issuer and 434,437 private placement warrants to acquire 434,437 shares of Issuer.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 17:21 UTC Exercise / conversionOptions to purchase Common Stock · Derivative 645,145 $0.00 Strike: $2.26 $0.00
Disclosure

SEC source: 0001213900-22-037684 · ownership.xml · derivative · entry 4

Capone Anthony · CIK 0001884688 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 645,145 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: These options became fully exercisable on January 23, 2022 with an expiration date of January 22, 2027. On July 1, 2022, Mr. Capone exercised options to purchase 645,145 shares of common stock for $2.26 a share. In connection with the exercise of the options, the Company withheld 89,767 shares to satisfy his tax withholding obligation upon the exercise and 201,102 shares to cover the exercise price.

F1 · derivative.expiration_date: These options became fully exercisable on January 23, 2022 with an expiration date of January 22, 2027. On July 1, 2022, Mr. Capone exercised options to purchase 645,145 shares of common stock for $2.26 a share. In connection with the exercise of the options, the Company withheld 89,767 shares to satisfy his tax withholding obligation upon the exercise and 201,102 shares to cover the exercise price.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 17:21 UTC Tax withholdingCommon Stock 201,102 $7.26 $1,460,000.52
Disclosure

SEC source: 0001213900-22-037684 · ownership.xml · nonDerivative · entry 3

Capone Anthony · CIK 0001884688 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,276

F1 · kind: These options became fully exercisable on January 23, 2022 with an expiration date of January 22, 2027. On July 1, 2022, Mr. Capone exercised options to purchase 645,145 shares of common stock for $2.26 a share. In connection with the exercise of the options, the Company withheld 89,767 shares to satisfy his tax withholding obligation upon the exercise and 201,102 shares to cover the exercise price.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 17:21 UTC Tax withholdingCommon Stock 89,767 $7.26 $651,708.42
Disclosure

SEC source: 0001213900-22-037684 · ownership.xml · nonDerivative · entry 2

Capone Anthony · CIK 0001884688 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 555,378

F1 · kind: These options became fully exercisable on January 23, 2022 with an expiration date of January 22, 2027. On July 1, 2022, Mr. Capone exercised options to purchase 645,145 shares of common stock for $2.26 a share. In connection with the exercise of the options, the Company withheld 89,767 shares to satisfy his tax withholding obligation upon the exercise and 201,102 shares to cover the exercise price.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 17:21 UTC Exercise / conversionCommon Stock 645,145 $2.26 $1,458,027.70
Disclosure

SEC source: 0001213900-22-037684 · ownership.xml · nonDerivative · entry 1

Capone Anthony · CIK 0001884688 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 645,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 21:22 UTC
Sugrue StephenChief Compliance Officer
GrantOptions to purchase Common Stock · Derivative 50,000 $0.00 Strike: $7.26 $0.00
Disclosure

SEC source: 0001213900-22-037686 · ownership.xml · derivative · entry 1

Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2032-07-01

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock.

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on July 1 of each of 2023, 2024, 2025 and 2026, subject to the terms of the Plan.

Read SEC document
April 28, 2022 Filed May 2, 2022 18:38 UTC
Merlin Mark DOCMO (Ambulnz Holdings, LLC)
GrantOptions to purchase Common Stock · Derivative 64,515 $0.00 Strike: $7.12 $0.00
Disclosure

SEC source: 0001213900-22-023285 · ownership.xml · derivative · entry 1

Merlin Mark DO · CIK 0001884702 · CMO (Ambulnz Holdings, LLC)

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,515

Underlying: Common Stock · 64,515 shares

Expires 2032-04-28

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock.

Read SEC document
April 28, 2022 Filed May 2, 2022 22:39 UTC
Sugrue StephenChief Compliance Officer
GrantOptions to purchase Common Stock · Derivative 100,000 $0.00 Strike: $7.12 $0.00
Disclosure

SEC source: 0001213900-22-023286 · ownership.xml · derivative · entry 1

Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-04-28

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). Each option represents the right to acquire one share of Common Stock.

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on January 1 of each of 2023, 2024, 2025 and 2026, subject to the terms of the Plan.

Read SEC document
April 07, 2022 Filed May 4, 2022 20:38 UTC
Sugrue StephenChief Compliance Officer
Exercise / conversionOption to Buy · Derivative 16,128 $0.00 Strike: $3.25 $0.00
Disclosure

SEC source: 0001213900-22-023979 · ownership.xml · derivative · entry 2

Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,128 shares

Expires 2031-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The number of shares subject to this tranche has previously erroneously been reported as 16,129 on a Form 3 filed on March 21, 2022. It should have been reported as 16,128. Therefore, this tranche has been fully exercised.

Read SEC document
April 07, 2022 Filed May 4, 2022 20:38 UTC
Sugrue StephenChief Compliance Officer
Exercise / conversionCommon Stock 16,128 $3.25 $52,416.00
Disclosure

SEC source: 0001213900-22-023979 · ownership.xml · nonDerivative · entry 1

Sugrue Stephen · CIK 0001917263 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,128

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 28, 2022 Filed Apr 26, 2022 10:07 UTC
Bienstock LeeChief Operating Officer
GrantOption to Buy · Derivative 100,000 $0.00 Strike: $7.15 $0.00
Disclosure

SEC source: 0001213900-22-021516 · ownership.xml · derivative · entry 3

Bienstock Lee · CIK 0001920525 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common stock · 100,000 shares

Expires not disclosed

F3 · derivative.exercise_date: Mr. Bienstock was granted 100,000 options on March 28, 2022 pursuant to the Plan, vesting 100% on March 28, 2023, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock.

F3 · derivative.expiration_date: Mr. Bienstock was granted 100,000 options on March 28, 2022 pursuant to the Plan, vesting 100% on March 28, 2023, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock.

Read SEC document
March 28, 2022 Filed Apr 26, 2022 10:07 UTC
Bienstock LeeChief Operating Officer
GrantOption to Buy · Derivative 320,122 $0.00 Strike: $7.15 $0.00
Disclosure

SEC source: 0001213900-22-021516 · ownership.xml · derivative · entry 2

Bienstock Lee · CIK 0001920525 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,122

Underlying: Common stock · 320,122 shares

Expires not disclosed

F2 · derivative.exercise_date: Mr. Bienstock was granted 320,122 options on March 28, 2022 pursuant to the Plan, vesting 25% on each of March 28, 2023, March 28, 2024, March 28, 2025 and March 28, 2026, in each case, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock.

F2 · derivative.expiration_date: Mr. Bienstock was granted 320,122 options on March 28, 2022 pursuant to the Plan, vesting 25% on each of March 28, 2023, March 28, 2024, March 28, 2025 and March 28, 2026, in each case, subject to the terms of the Plan. Each option represents the right to acquire one share of Common Stock.

Read SEC document
March 28, 2022 Filed Apr 26, 2022 10:07 UTC
Bienstock LeeChief Operating Officer
GrantRestricted Stock Unit 146,853 $0.00 $0.00
Disclosure

SEC source: 0001213900-22-021516 · ownership.xml · nonDerivative · entry 1

Bienstock Lee · CIK 0001920525 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,853

F1 · shares: Mr. Bienstock was granted 146,853 restricted stock units on March 28, 2022 pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan")., vesting 25% on each of March 28, 2023, March 28, 2024, March 28, 2025 and March 28, 2026. Each restricted stock unit represents the right to receive, upon vesting, one share of Common Stock.

Read SEC document
December 09, 2021 Filed Jan 27, 2022 17:17 UTC
Oberholzer Adriaan StephanusChief Financial Officer
GrantOptions to purchase Common Stock · Derivative 356,553 $0.00 Strike: $8.97 $0.00
Disclosure

SEC source: 0001213900-22-004058 · ownership.xml · derivative · entry 1

Oberholzer Adriaan Stephanus · CIK 0001885481 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 356,553

Underlying: Common Stock · 356,553 shares

Expires 2031-12-09

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each cash, subject to the terms of the Plan.

Read SEC document
December 09, 2021 Filed Jan 27, 2022 16:56 UTC
Oberholzer Adriaan StephanusChief Financial Officer
GrantOptions to purchase Common Stock · Derivative 356,553 $0.00 Strike: $8.97 $0.00
Disclosure

SEC source: 0001213900-22-004015 · ownership.xml · derivative · entry 1

Oberholzer Adriaan Stephanus · CIK 0001885481 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 356,553

Underlying: Common Stock · 356,553 shares

Expires 2031-12-09

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each case, subject to the terms of the Plan.

Read SEC document
December 09, 2021 Filed Jan 27, 2022 17:15 UTC GrantOptions to purchase Common Stock · Derivative 1,018,932 $0.00 Strike: $8.97 $0.00
Disclosure

SEC source: 0001213900-22-004055 · ownership.xml · derivative · entry 1

Capone Anthony · CIK 0001884688 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,018,932

Underlying: Common Stock · 1,018,932 shares

Expires 2031-12-09

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each cash, subject to the terms of the Plan.

Read SEC document
December 09, 2021 Filed Jan 27, 2022 16:55 UTC GrantOptions to purchase Common Stock · Derivative 1,018,932 $0.00 Strike: $8.97 $0.00
Disclosure

SEC source: 0001213900-22-004013 · ownership.xml · derivative · entry 1

Capone Anthony · CIK 0001884688 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,018,932

Underlying: Common Stock · 1,018,932 shares

Expires 2031-12-09

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each case, subject to the terms of the Plan.

Read SEC document
December 09, 2021 Filed Jan 27, 2022 17:32 UTC
ROSENBERG NORMANCFO (Ambulnz Holdings, LLC)
GrantOptions to purchase Common Stock · Derivative 205,097 $0.00 Strike: $8.97 $0.00
Disclosure

SEC source: 0001213900-22-004078 · ownership.xml · derivative · entry 1

ROSENBERG NORMAN · CIK 0001439758 · CFO (Ambulnz Holdings, LLC)

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,097

Underlying: Common Stock · 205,097 shares

Expires 2031-12-09

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each cash, subject to the terms of the Plan.

Read SEC document
December 09, 2021 Filed Jan 27, 2022 17:06 UTC
ROSENBERG NORMANCFO (Ambulnz Holdings, LLC)
GrantOptions to purchase Common Stock · Derivative 205,097 $0.00 Strike: $8.97 $0.00
Disclosure

SEC source: 0001213900-22-004036 · ownership.xml · derivative · entry 1

ROSENBERG NORMAN · CIK 0001439758 · CFO (Ambulnz Holdings, LLC)

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,097

Underlying: Common Stock · 205,097 shares

Expires 2031-12-09

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each case, subject to the terms of the Plan.

Read SEC document
December 09, 2021 Filed Jan 27, 2022 17:36 UTC
VASHOVSKY STANLEYDirector · Chief Executive Officer · 10% owner
GrantOptions to purchase Common Stock · Derivative 1,018,932 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004082 · ownership.xml · derivative · entry 1

VASHOVSKY STANLEY · CIK 0001409310 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,018,932

Underlying: Common Stock · 1,018,932 shares

Expires 2031-12-09

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each cash, subject to the terms of the Plan.

Read SEC document
December 09, 2021 Filed Jan 27, 2022 17:09 UTC
VASHOVSKY STANLEYDirector · Chief Executive Officer · 10% owner
GrantOptions to purchase Common Stock · Derivative 1,018,932 $0.00 Strike: $8.97 $0.00
Disclosure

SEC source: 0001213900-22-004041 · ownership.xml · derivative · entry 1

VASHOVSKY STANLEY · CIK 0001409310 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,018,932

Underlying: Common Stock · 1,018,932 shares

Expires 2031-12-09

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 9, 2022 through December 9, 2025, in each case, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:28 UTC
Merlin Mark DOCMO (Ambulnz Holdings, LLC)
GrantOptions to purchase Common Stock · Derivative 1,000 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004073 · ownership.xml · derivative · entry 1

Merlin Mark DO · CIK 0001884702 · CMO (Ambulnz Holdings, LLC)

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each cash, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:03 UTC
Merlin Mark DOCMO (Ambulnz Holdings, LLC)
GrantOptions to purchase Common Stock · Derivative 1,000 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004032 · ownership.xml · derivative · entry 1

Merlin Mark DO · CIK 0001884702 · CMO (Ambulnz Holdings, LLC)

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each case, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:04 UTC
Witkowski Michael S.Chief Compliance Officer
GrantOptions to purchase Common Stock · Derivative 1,000 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004034 · ownership.xml · derivative · entry 1

Witkowski Michael S. · CIK 0001884698 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each case, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:30 UTC
Witkowski Michael S.Chief Compliance Officer
GrantOptions to purchase Common Stock · Derivative 1,000 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004075 · ownership.xml · derivative · entry 1

Witkowski Michael S. · CIK 0001884698 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each cash, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:19 UTC GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004060 · ownership.xml · derivative · entry 1

Fillo Christopher · CIK 0001884629 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:11 UTC GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004045 · ownership.xml · derivative · entry 1

Fillo Christopher · CIK 0001884629 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:07 UTC
KATZ STEVENDirector
GrantOption to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004038 · ownership.xml · derivative · entry 1

KATZ STEVEN · CIK 0001202928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:24 UTC GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004069 · ownership.xml · derivative · entry 1

TRAVERS JAMES M · CIK 0001258177 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 16:53 UTC GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004008 · ownership.xml · derivative · entry 1

TRAVERS JAMES M · CIK 0001258177 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:34 UTC
KATZ STEVENDirector
GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004080 · ownership.xml · derivative · entry 1

KATZ STEVEN · CIK 0001202928 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 22:26 UTC GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004071 · ownership.xml · derivative · entry 1

Burdiek Michael J · CIK 0001324293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 22:01 UTC GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004029 · ownership.xml · derivative · entry 1

Burdiek Michael J · CIK 0001324293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 17:20 UTC
Tendler Ely DDirector · General Counsel and Secretary
GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004062 · ownership.xml · derivative · entry 1

Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 16:58 UTC
Tendler Ely DDirector · General Counsel and Secretary
GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004021 · ownership.xml · derivative · entry 1

Tendler Ely D · CIK 0001331867 · Director · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 22:22 UTC
Smedra IraDirector
GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004065 · ownership.xml · derivative · entry 1

Smedra Ira · CIK 0001892208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each cash, subject to the terms of the Plan.

Read SEC document
December 07, 2021 Filed Jan 27, 2022 21:59 UTC
Smedra IraDirector
GrantOptions to purchase Common Stock · Derivative 79,208 $0.00 Strike: $8.80 $0.00
Disclosure

SEC source: 0001213900-22-004024 · ownership.xml · derivative · entry 1

Smedra Ira · CIK 0001892208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 79,208 shares

Expires 2031-12-07

F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").

F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in three equal annual installments beginning on December 7, 2022 through December 7, 2024, in each case, subject to the terms of the Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.